| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |